Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 28, 2011; 17(24): 2897-2908
Published online Jun 28, 2011. doi: 10.3748/wjg.v17.i24.2897
Published online Jun 28, 2011. doi: 10.3748/wjg.v17.i24.2897
Syndrome | Gene | Life-time risk | Relative risk |
FAMMM | CDKN2A | 10%-15% | 20-34 |
HBOC | BRCA2 | 5% | 10 |
HBOC | BRCA1 | Not known | 2 |
Hereditary pancreatitis | PRSS1/TRY1 | 30%-50% | 50 |
Lynch syndrome | MLH1/MSH2 | Not known | Not known |
Peutz–Jeghers syndrome | STK11/LKB1 | 36% | 136 |
FAP | APC | Not known | 4 |
Li–Faumeni syndrome | p53 | Not known | Not known |
FPC | Not known | Up to 50% | 18-57 |
- Citation: Zavoral M, Minarikova P, Zavada F, Salek C, Minarik M. Molecular biology of pancreatic cancer. World J Gastroenterol 2011; 17(24): 2897-2908
- URL: https://www.wjgnet.com/1007-9327/full/v17/i24/2897.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i24.2897